These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 16620286

  • 1. A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited.
    Laleman W, Vander Elst I, Zeegers M, Servaes R, Libbrecht L, Roskams T, Fevery J, Nevens F.
    Eur J Clin Invest; 2006 Apr; 36(4):242-9. PubMed ID: 16620286
    [Abstract] [Full Text] [Related]

  • 2. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.
    Laleman W, Van Landeghem L, Van der Elst I, Zeegers M, Fevery J, Nevens F.
    Gastroenterology; 2007 Feb; 132(2):709-19. PubMed ID: 17258737
    [Abstract] [Full Text] [Related]

  • 3. Chronological production of thioacetamide-induced cirrhosis in the rat with no mortality.
    Norasingha A, Pradidarcheep W, Chayaburakul K.
    J Med Assoc Thai; 2012 Jan; 95 Suppl 1():S173-7. PubMed ID: 23964462
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
    Cao H, Xu J, Liu H, Meng FB, Qiu JF, Wu ZY.
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
    [Abstract] [Full Text] [Related]

  • 6. Non-alcoholic steatohepatitis induces non-fibrosis-related portal hypertension associated with splanchnic vasodilation and signs of a hyperdynamic circulation in vitro and in vivo in a rat model.
    Francque S, Wamutu S, Chatterjee S, Van Marck E, Herman A, Ramon A, Jung A, Vermeulen W, De Winter B, Pelckmans P, Michielsen P.
    Liver Int; 2010 Mar; 30(3):365-75. PubMed ID: 19840249
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A novel canine model of portal vein stenosis plus thioacetamide administration-induced cirrhotic portal hypertension with hypersplenism.
    Lin D, Wu X, Ji X, Zhang Q, Lin Y, Chen W, Jin W, Deng L, Chen Y, Chen B, Li J.
    Cell Biochem Biophys; 2012 Jan; 62(1):245-55. PubMed ID: 21904911
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Application of metabonomics on an experimental model of fibrosis and cirrhosis induced by thioacetamide in rats.
    Constantinou MA, Theocharis SE, Mikros E.
    Toxicol Appl Pharmacol; 2007 Jan 01; 218(1):11-9. PubMed ID: 17113614
    [Abstract] [Full Text] [Related]

  • 12. Changes in systemic and splanchnic hemodynamics after orthotopic liver transplantation in cirrhotic rats.
    Cao H, Wu Z, Zhang X, Zhang H, Chen Z, Kuang Y.
    Chin Med J (Engl); 2000 Dec 01; 113(12):1108-11. PubMed ID: 11776147
    [Abstract] [Full Text] [Related]

  • 13. Reproducible production of thioacetamide-induced macronodular cirrhosis in the rat with no mortality.
    Li X, Benjamin IS, Alexander B.
    J Hepatol; 2002 Apr 01; 36(4):488-93. PubMed ID: 11943419
    [Abstract] [Full Text] [Related]

  • 14. Treatment of bile duct-ligated rats with the nitric oxide synthase transcription enhancer AVE 9488 ameliorates portal hypertension.
    Biecker E, Trebicka J, Kang A, Hennenberg M, Sauerbruch T, Heller J.
    Liver Int; 2008 Mar 01; 28(3):331-8. PubMed ID: 18290775
    [Abstract] [Full Text] [Related]

  • 15. Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension.
    Hernández-Guerra M, García-Pagán JC, Turnes J, Bellot P, Deulofeu R, Abraldes JG, Bosch J.
    Hepatology; 2006 Mar 01; 43(3):485-91. PubMed ID: 16496307
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Caffeine ameliorates hemodynamic derangements and portosystemic collaterals in cirrhotic rats.
    Hsu SJ, Lee FY, Wang SS, Hsin IF, Lin TY, Huang HC, Chang CC, Chuang CL, Ho HL, Lin HC, Lee SD.
    Hepatology; 2015 May 01; 61(5):1672-84. PubMed ID: 25557829
    [Abstract] [Full Text] [Related]

  • 19. Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension.
    Laviña B, Gracia-Sancho J, Rodríguez-Vilarrupla A, Chu Y, Heistad DD, Bosch J, García-Pagán JC.
    Gut; 2009 Jan 01; 58(1):118-25. PubMed ID: 18829979
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.